UBS Downgrades Mettler-Toledo (MTD) to Neutral
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
UBS downgraded Mettler-Toledo (NYSE: MTD) from Buy to Neutral with a price target of $415.00 (from $389.00) on balanced risk/reward.
Analyst Jonathan Groberg commented, "Our view on MTD's operating fundamentals and management's premium execution has not changed at all. If anything, the firm's recent investor day and another beat and raise quarter give us more conviction in the firm's strategy and management's execution ability. However, at the current valuation, both absolute and relative, it is hard to argue that this superior performance is not appreciated by the street or that the stock is mis-priced. Given valuation and potential global macro uncertainty we think the risk/reward to investors at current prices is balanced and we move to Neutral."
Shares of Mettler-Toledo closed at $396.14 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- M&T Bank (MTB) PT Raised to $165 at FBR Capital Following 4Q Beat
- PacWest Bancorp (PACW) PT Raised to $60.50 at FIG Partners Following 4Q Report
- UPDATE: SunTrust Robinson Humphrey Downgrades Pennsylvania Real Estate Investment Trust (PEI) to Hold
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst PT Change, Downgrades
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!